These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 36136834)

  • 1. The Development and Implementation of Airflow Visualization Studies ("Smoke" Studies) as a Training Tool in Aseptic Hospital Compounding Facilities.
    Borgonje PE; Wibier L; Noordman P; Woerdenbag HJ; Gareb B
    Pharmacy (Basel); 2022 Aug; 10(5):. PubMed ID: 36136834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reducing the risk of non-sterility of aseptic handling in hospital pharmacies, part B: risk control.
    Boom FA; Ris JM; Veenbaas T; Le Brun PPH; Touw D
    Eur J Hosp Pharm; 2021 Nov; 28(6):325-330. PubMed ID: 32385068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and Implementation of an Ultraviolet-Dye-Based Qualification Procedure for Hand Washing and Disinfection to Improve Quality Assurance of Pharmacy Preparations and Compounding, Especially in Cleanrooms: A Pilot Study.
    Knol CWJ; Stob PH; Woerdenbag HJ
    Pharmacy (Basel); 2024 Apr; 12(3):. PubMed ID: 38804465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survey of sterile admixture practices in canadian hospital pharmacies: part 2. More results and discussion.
    Warner T; Nishi C; Checkowski R; Hall KW
    Can J Hosp Pharm; 2009 May; 62(3):192-203. PubMed ID: 22478890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survey of sterile admixture practices in canadian hospital pharmacies: part 1. Methods and results.
    Warner T; Nishi C; Checkowski R; Hall KW
    Can J Hosp Pharm; 2009 Mar; 62(2):100-11. PubMed ID: 22478875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential for airborne contamination in turbulent- and unidirectional-airflow compounding aseptic isolators.
    Peters GF; McKeon MR; Weiss WT
    Am J Health Syst Pharm; 2007 Mar; 64(6):622-31. PubMed ID: 17353571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microbiological controls of aseptic handling in Dutch hospital pharmacies: Results, limits, and methods for assessing.
    Boom FA; Le Brun PPH; Bühringer S; Sirks M; Touw DJ
    Eur J Pharm Sci; 2022 Aug; 175():106228. PubMed ID: 35640785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Validation of aseptic technique of parenteral nutrition compounding in a pharmacy service according to USP Chapter 797].
    Romero Jiménez RM; Pernía López MS; Sánchez Fresneda MN; Sanjurjo Sáez M
    Nutr Hosp; 2013; 28(5):1494-7. PubMed ID: 24160206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Demystifying dynamic smoke pattern tests for sterile compounding pharmacies.
    Rhoads R; Exner L; Wagner JT
    Am J Health Syst Pharm; 2020 Jan; 77(1):56-60. PubMed ID: 31756250
    [No Abstract]   [Full Text] [Related]  

  • 10. Improving the aseptic transfer procedures in hospital pharmacies part C: evaluation and redesign of the transfer process.
    Boom FA; Le Brun PPH; Boehringer S; Kosterink JGW; Touw DJ
    Eur J Hosp Pharm; 2022 Jan; 29(1):12-17. PubMed ID: 34930789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of cross-contamination control in biological safety cabinet for biotech/pharmaceutical manufacturing process.
    Hu SC; Shiue A; Tu JX; Liu HY; Chiu RB
    Environ Sci Pollut Res Int; 2015 Dec; 22(23):19264-72. PubMed ID: 26257118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating containment effectiveness of A2 and B2 biological safety cabinets.
    Taylor AV; Baker N; Hulsey M; Bennett CC; Meiners M; Gonzales BA
    Am J Health Syst Pharm; 2019 Apr; 76(9):599-607. PubMed ID: 31361829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A collaborative effort to comply with USP chapter 797 for compounding sterile preparations for investigational use.
    Formea CM; Weiss WT; McCluskey SV
    Am J Health Syst Pharm; 2008 Jul; 65(13):1266-9. PubMed ID: 18574018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microbiological validation of a robot for the sterile compounding of injectable non-hazardous medications in a hospital environment.
    Sabatini L; Paolucci D; Marinelli F; Pianetti A; Sbaffo M; Bufarini C; Sisti M
    Eur J Hosp Pharm; 2020 Mar; 27(e1):e63-e68. PubMed ID: 32296508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microbiological monitoring during aseptic handling: Methods, limits and interpretation of results.
    Boom FA; Brun PPHL; Bühringer S; Touw DJ
    Eur J Pharm Sci; 2020 Dec; 155():105540. PubMed ID: 32898638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Practices of pharmacies that compound extemporaneous formulations.
    Treadway AK; Craddock D; Leff R
    Am J Health Syst Pharm; 2007 Jul; 64(13):1403-9. PubMed ID: 17592006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sterile Compounding Pharmacies: States That Do and Do Not Require Compliance With USP <797> Versus FDA 483s.
    Wilson M
    Ther Innov Regul Sci; 2016 May; 50(3):279-303. PubMed ID: 30227076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monitoring minimization of grade B environments based on risk assessment using three-dimensional airflow measurements and computer simulation.
    Katayama H; Higo T; Tokunaga Y; Katoh S; Hiyama Y; Morikawa K
    PDA J Pharm Sci Technol; 2008; 62(4):244-55. PubMed ID: 19174953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and Construction of a Radiochemistry Laboratory and cGMP-Compliant Radiopharmacy Facility.
    Asor A; Metebi A; Smith K; Last K; Strauss E; Fan J
    Pharmaceuticals (Basel); 2024 May; 17(6):. PubMed ID: 38931348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cleanrooms and tissue banking how happy I could be with either GMP or GTP?
    Klykens J; Pirnay JP; Verbeken G; Giet O; Baudoux E; Jashari R; Vanderkelen A; Ectors N
    Cell Tissue Bank; 2013 Dec; 14(4):571-8. PubMed ID: 23288450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.